This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Salidroside inhibits the proliferation and migration of gastric carcinoma cells and tumor growth via the activation of ERS-dependent autophagy and apoptosis
Wei Yan, Kai Li, Amin Buhe, Tianxiong Li, Peirong Tian, Jun Hong
TL;DR
This paper is a retraction of a previous study that claimed salidroside inhibits gastric cancer cell growth through autophagy and apoptosis.
Contribution
The paper formally retracts a prior claim about salidroside's anti-cancer effects.
Findings
The original study's findings are no longer considered valid.
The retraction highlights the need for further research on salidroside's effects.
Abstract
Retraction of ‘Salidroside inhibits the proliferation and migration of gastric carcinoma cells and tumor growth via the activation of ERS-dependent autophagy and apoptosis' by Wei Yan et al., RSC Adv., 2019, 9, 25655–25666, https://doi.org/10.1039/C9RA00044E.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMedicinal Plants and Bioactive Compounds · Lipid metabolism and disorders · Flavonoids in Medical Research